443916-94-7

Basic information

• Product Name: 7(1H)-Indolizinone,hexahydro-,(8aS)-(9CI)
• Synonyms: 7(1H)-Indolizinone,hexahydro-,(8aS)-(9CI)
• CAS NO: 443916-94-7
• Molecular Formula: C8H13NO
• Molecular Weight: 0
• Product Categories: AMINETERTIARY
• Mol File: 443916-94-7.mol
• Article Data: 21

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 7(1H)-Indolizinone,hexahydro-,(8aS)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 7(1H)-Indolizinone,hexahydro-,(8aS)-(9CI)(443916-94-7)
• EPA Substance Registry System: 7(1H)-Indolizinone,hexahydro-,(8aS)-(9CI)(443916-94-7)

Safety Data

• Hazardous Substances Data: 443916-94-7(Hazardous Substances Data)

Upstream product

• 74991-96-1 7-oxo-octahydro-indolizine-8-carboxylic acid ethyl ester 
• 87265-36-9 4-(4,4-Diethoxy-butylamino)-butan-2-one 
• 23692-06-0 diethyl 7-oxooctahydroindolizin-6,8-dicarboxylate 
• 337974-50-2 8-[(tert-butoxycarbonyl)amino]-1-[(4'-methylphenyl)sulfonyl]-1-octen-3-one 
• 72130-69-9 ethyl 7-oxo-1,2,3,5,6,7-hexahydroindolizine-8-carboxylate 
• 74991-93-8 ethyl 3-(2-thioxopyrrolidin-1-yl)propanoate 
• 74991-94-9 3-{2-[1-Ethoxycarbonyl-meth-(E)-ylidene]-pyrrolidin-1-yl}-propionic acid ethyl ester 
• 443797-19-1 (+/-)-1-(t-butoxycarbonyl)-2-(2-oxo-3-butenyl)pyrrolidine 
• 287730-08-9 1-(t-Butoxycarbonyl)-2-[4-(p-toluenesulfonyl)-2-oxobutyl]pyrrolidine 
• 6346-09-4 4-aminobutyrylaldehyde diethylacetal 
• 27132-81-6 2,4-dimethyl-penta-1,4-dien-3-one 
• 78-94-4 methyl vinyl ketone 
• 1312456-12-4 C₈H₁₃NO 
• 98303-20-9 1-(tert-butoxycarbonyl)piperidine-2-carboxylic acid 

Downstream Products

• 476493-34-2 7-cyanooctahydroindolizine 
• 1428760-99-9 4-(1,2,3,5,8,8a-hexahydroindolizin-7-yl)aniline 
• 1428761-00-5 4-(1,2,3,5,6,8a-hexahydroindolizin-7-yl)aniline 
• 1428761-01-6 4-(octahydroindolizin-7-yl)aniline 

Relevant articles and documents

1 -(CYCLOPENT-2-EN-1 -YL)-3-(2-HYDROXY-3-(ARYLSULFONYL)PHENYL)UREA DERIVATIVES AS CXCR2 INHIBITORS

The invention relates to 1-(3-sulfonylphenyl)-3-(cyclopent-2-en-1-yl)urea derivatives, and their use in treating or preventing diseases and conditions mediated by the CXCR2 receptor. In addition, the invention relates to compositions containing the derivatives and processes for their preparation.

PROTEIN KINASE C INHIBITORS AND USES THEREOF

This disclosure concerns compounds which are useful as inhibitors of protein kinase C (PKC) and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC. This disclosure also relates to ph

HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF

Provided herein are spiro-cyclic compounds, methods of synthesis, and methods of use thereof. The compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, including, e.g., neurological disorders and metab